Jeffrey E. Ming
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jeffrey E. Ming.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Erich Roessler; Y. Du; Jose L. Mullor; Esther Casas; William Allen; Gabriele Gillessen-Kaesbach; Elizabeth Roeder; Jeffrey E. Ming; Ariel Ruiz i Altaba; Maximilian Muenke
Diminished Sonic Hedgehog (Shh) signaling is associated with the most common forebrain defect in humans, holoprosencephaly (HPE), which includes cyclopia, a phenotype also seen in mice and other vertebrates with defective Shh signaling. The secreted protein Shh acts as a crucial factor that patterns the ventral forebrain and is required for the division of the primordial eye field and brain into two discrete halves. Gli2 is one of three vertebrate transcription factors implicated as obligatory mediators of Shh signal transduction. Here, we show that loss-of-function mutations in the human GLI2 gene are associated with a distinctive phenotype (within the HPE spectrum) whose primary features include defective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavage abnormalities, and HPE-like midfacial hypoplasia. We also demonstrate that these mutations lack GLI2 activity. We report on a functional association between GLI2 and human disease and highlight the role of GLI2 in human head development.
American Journal of Human Genetics | 2002
Jeffrey E. Ming; Maximilian Muenke
Multiple genetic and environmental factors likely play a role in the phenotypic expression of many Mendelian disorders. Understanding the biologic role of the genes associated with human disease may guide future explorations of additional modifier genes. For example, with HPE, there are several possible categories of additional candidate genes and potential sites of interaction. First, there are genes encoding proteins that are in the signaling pathways for identified disease genes (e.g., Shh and nodal signaling). Second, genes involved in the relevant developmental processes are potential candidate genes for human diseases (dorsal-ventral patterning of the forebrain, other processes in midline forebrain development, prechordal mesoderm induction). Third, genes involved in synthesis or metabolism of teratogenic agents (cholesterol biosynthesis, retinoic acid metabolism) could also be potential genetic contributors. Multiple genetic hits or environmental exposures may be required for clinical expression of many Mendelian disorders. Conceptions of a disease being the result of mutations in a single gene should take into account the overlap between Mendelian and multifactorial disorders. Indeed, as more detail emerges demonstrating the impact of genomic and environmental variability on phenotype, we may reconceptualize classic Mendelian and complex multifactorial disorders as two ends of a continuum of disease causation, with the gradient reflecting the relative independence of a given mutation in producing the disease phenotype. It may be useful to remember that “genomes speak biochemistry, not phenotype” (Plasterk 1999). Future studies will focus both on the identification of additional genes involved with these human diseases and on the understanding of their biologic interactions. Such information will lend greater insight into the complex genetic and environmental influences that lead to phenotypic expression of a trait.
Human Genetics | 2002
Jeffrey E. Ming; Michelle E. Kaupas; Erich Roessler; Han G. Brunner; Mahin Golabi; Mustafa Tekin; Robert F. Stratton; Eva Sujansky; Sherri J. Bale; Maximilian Muenke
Abstract. Holoprosencephaly (HPE) is the most commonly occurring congenital structural forebrain anomaly in humans. HPE is associated with mental retardation and craniofacial malformations. The genetic causes of HPE have recently begun to be identified, and we have previously shown that HPE can be caused by haploinsufficiency for SONIC HEDGEHOG (SHH). We hypothesize that mutations in genes encoding other components of the SHH signaling pathway could also be associated with HPE. PATCHED-1 (PTCH), the receptor for SHH, normally acts to repress SHH signaling. This repression is relieved when SHH binds to PTCH. We analyzed PTCH as a candidate gene for HPE. Four different mutations in PTCH were detected in five unrelated affected individuals. We predict that by enhancing the repressive activity of PTCH on the SHH pathway, these mutations cause decreased SHH signaling, and HPE results. The mutations could affect the ability of PTCH to bind SHH or perturb the intracellular interactions of PTCH with other proteins involved in SHH signaling. These findings further demonstrate the genetic heterogeneity associated with HPE, as well as showing that mutations in different components of a single signaling pathway can result in the same clinical condition.
Molecular Cytogenetics | 2008
Blake C. Ballif; Aaron Theisen; Justine Coppinger; Gordon C. Gowans; Joseph H. Hersh; Suneeta Madan-Khetarpal; Karen Schmidt; Raymond Tervo; Luis F. Escobar; Christopher A. Friedrich; Marie McDonald; Lindsey Campbell; Jeffrey E. Ming; Elaine H. Zackai; Bassem A. Bejjani; Lisa G. Shaffer
BackgroundInterstitial deletions of 3q29 have been recently described as a microdeletion syndrome mediated by nonallelic homologous recombination between low-copy repeats resulting in an ~1.6 Mb common-sized deletion. Given the molecular mechanism causing the deletion, the reciprocal duplication is anticipated to occur with equal frequency, although only one family with this duplication has been reported.ResultsIn this study we describe 14 individuals with microdeletions of 3q29, including one family with a mildly affected mother and two affected children, identified among 14,698 individuals with idiopathic mental retardation who were analyzed by array CGH. Eleven individuals had typical 1.6-Mb deletions. Three individuals had deletions that flank, span, or partially overlap the commonly deleted region. Although the clinical presentations of individuals with typical-sized deletions varied, several features were present in multiple individuals, including mental retardation and microcephaly. We also identified 19 individuals with duplications of 3q29, five of which appear to be the reciprocal duplication product of the 3q29 microdeletion and 14 of which flank, span, or partially overlap the common deletion region. The clinical features of individuals with microduplications of 3q29 also varied with few common features. De novo and inherited abnormalities were found in both the microdeletion and microduplication cohorts illustrating the need for parental samples to fully characterize these abnormalities.ConclusionOur report demonstrates that array CGH is especially suited to identify chromosome abnormalities with unclear or variable presentations.
Molecular Medicine Today | 1998
Jeffrey E. Ming; Erich Roessler; Maximilian Muenke
Sonic hedgehog (Shh) is a morphogen that is crucial for normal development of a variety of organ systems, including the brain and spinal cord, the eye, craniofacial structures, and the limbs. Mutations in the human SHH gene and genes that encode its downstream intracellular signaling pathway cause several clinical disorders. These include holoprosencephaly (HPE, the most common anomaly of the developing forebrain), nevoid basal cell carcinoma syndrome, sporadic tumors, including basal cell carcinomas, and three distinct congenital disorders: Greig syndrome Pallister-Hall syndrome, and isolated postaxial polydactyly. These conditions caused by abnormalities in the SHH pathway demonstrate the crucial role of SHH in complex developmental processes, and molecular analyses of these disorders provide insight into the normal function of the SHH pathway in human development.
Clinical Genetics | 2008
Jeffrey E. Ming; Maximilian Muenke
Holoprosencephaly (HPE), a common developmental defect affecting the forebrain and face, is etiologically heterogeneous and exhibits wide phenotypic variation. Graded degrees of severity of the brain malformation are also reflected in the highly variable craniofacial malformations associated with HPE. In addition, individuals with microforms of HPE, who usually have normal cognition and normal brain imaging, are at risk for having children with HPE. Some obligate carriers for HPE may not have any phenotypic abnormalities. Recurrent chromosomal rearrangements in individuals with HPE suggest loci containing genes important for brain development, and abnormalities in these genes may result in HPE. Recently, Sonic Hedgehog (SHH) was the first gene identified as causing HPE in humans. Proper function of SHH depends on cholesterol modification. Other candidate genes that may be involved in HPE include components of the SHH pathway, elements involved in cholesterol metabolism, and genes expressed in the developing forebrain.
American Journal of Medical Genetics | 2001
Luisa Nanni; Jeffrey E. Ming; Y. Du; Roger K. Hall; Michael J. Aldred; Agnes Bankier; Maximilian Muenke
Solitary median maxillary central incisor (SMMCI) or single central incisor is a rare dental anomaly. It has been reported in holoprosencephaly (HPE) cases with severe facial anomalies or as a microform in autosomal dominant HPE (ADHPE). In our review of the literature, we note that SMMCI may also occur as an isolated finding or in association with other systemic abnormalities. These anomalies include short stature, pituitary insufficiency, microcephaly, choanal atresia, midnasal stenosis, and congenital nasal pyriform aperture stenosis. SMMCI can also be a feature of recognized syndromes or associations or a finding in patients with specific chromosomal abnormalities. We performed a molecular study on a cohort of 13 SMMCI patients who did not have HPE. We studied two genes, Sonic Hedgehog (SHH) and SIX3, in which mutations have been reported in patients showing SMMCI as part of the HPE spectrum. A new missense mutation in SHH (I111F), segregating in one SMMCI family, was identified. Our results suggest that this mutation may be specific for the SMMCI phenotype since it has not been found in the HPE population or in normal controls. Published 2001 Wiley-Liss, Inc.
American Journal of Medical Genetics Part A | 2011
Mark C. Hannibal; Kati J. Buckingham; Sarah B. Ng; Jeffrey E. Ming; Anita E. Beck; Margaret J. McMillin; Heidi I. Gildersleeve; Abigail W. Bigham; Holly K. Tabor; Mefford Hc; Joseph Cook; Koh-ichiro Yoshiura; Tadashi Matsumoto; Naomichi Matsumoto; Noriko Miyake; Hidefumi Tonoki; Kenji Naritomi; Tadashi Kaname; Toshiro Nagai; Hirofumi Ohashi; Kenji Kurosawa; Jia Woei Hou; Tohru Ohta; Deshung Liang; Akira Sudo; Colleen A. Morris; Siddharth Banka; Graeme C.M. Black; Jill Clayton-Smith; Deborah A. Nickerson
Kabuki syndrome is a rare, multiple malformation disorder characterized by a distinctive facial appearance, cardiac anomalies, skeletal abnormalities, and mild to moderate intellectual disability. Simplex cases make up the vast majority of the reported cases with Kabuki syndrome, but parent‐to‐child transmission in more than a half‐dozen instances indicates that it is an autosomal dominant disorder. We recently reported that Kabuki syndrome is caused by mutations in MLL2, a gene that encodes a Trithorax‐group histone methyltransferase, a protein important in the epigenetic control of active chromatin states. Here, we report on the screening of 110 families with Kabuki syndrome. MLL2 mutations were found in 81/110 (74%) of families. In simplex cases for which DNA was available from both parents, 25 mutations were confirmed to be de novo, while a transmitted MLL2 mutation was found in two of three familial cases. The majority of variants found to cause Kabuki syndrome were novel nonsense or frameshift mutations that are predicted to result in haploinsufficiency. The clinical characteristics of MLL2 mutation‐positive cases did not differ significantly from MLL2 mutation‐negative cases with the exception that renal anomalies were more common in MLL2 mutation‐positive cases. These results are important for understanding the phenotypic consequences of MLL2 mutations for individuals and their families as well as for providing a basis for the identification of additional genes for Kabuki syndrome.
American Journal of Medical Genetics Part A | 2005
Linlea Armstrong; Azza Abd El Moneim; Kirk Aleck; David J. Aughton; Clarisse Baumann; Stephen R. Braddock; Gabriele Gillessen-Kaesbach; John M. Graham; Theresa A. Grebe; Karen W. Gripp; Bryan D. Hall; Raoul C. M. Hennekam; Alasdair G. W. Hunter; Kim M. Keppler-Noreuil; Didier Lacombe; Angela E. Lin; Jeffrey E. Ming; Nancy Mizue Kokitsu-Nakata; Sarah M. Nikkel; Nicole Philip; Annick Raas-Rothschild; Annemarie Sommer; Alain Verloes; Claudia Walter; Dagmar Wieczorek; Marc S. Williams; Elaine H. Zackai; Judith Allanson
Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome. This study of Kabuki syndrome had two objectives. The first was to further describe the syndrome features. In order to do so, clinical geneticists were asked to submit cases—providing clinical photographs and completing a phenotype questionnaire for individuals in whom they felt the diagnosis of Kabuki syndrome was secure. All submitted cases were reviewed by four diagnosticians familiar with Kabuki syndrome. The diagnosis was agreed upon in 48 previously unpublished individuals. Our data on these 48 individuals show that Kabuki syndrome variably affects the development and function of many organ systems. The second objective of the study was to explore possible etiological clues found in our data and from review of the literature. We discuss advanced paternal age, cytogenetic abnormalities, and familial cases, and explore syndromes with potentially informative overlapping features. We find support for a genetic etiology, with a probable autosomal dominant mode of inheritance, and speculate that there is involvement of the interferon regulatory factor 6 (IRF6) gene pathway. Very recently, a microduplication of 8p has been described in multiple affected individuals, the proportion of individuals with the duplication is yet to be determined.
Human Genetics | 1999
Jozef Gecz; Elizabeth Baker; Andrew Donnelly; Jeffrey E. Ming; Donna M. McDonald-McGinn; Nancy B. Spinner; Elaine H. Zackai; Grant R. Sutherland; John C. Mulley
Börjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation, which maps by linkage to the q26 region of the human X chromosome. We have identified a male patient with BFLS-like features and a duplication, 46,Y,dup(X)(q26q28), inherited from his phenotypically normal mother. Fluorescence in situ hybridisation using yeast artificial chromosome clones from Xq26 localised the duplication breakpoint to an ∼400-kb interval in the Xq26.3 region between DXS155 and DXS294/DXS730. Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor homologous factor gene, FHF2, within the duplication breakpoint interval. The gene structure of FHF2 was determined and two new exons were identified, including a new 5′ end exon, 1B. FHF2 is a large gene extending over ∼200 kb in Xq26.3 and is composed of at least seven exons. It shows tissue-specific alternative splicing and alternative transcription starts. Northern blot hybridisation showed highest expression in brain and skeletal muscle. The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.